Search for Clinical Trial Results
Neuroectodermal Tumors, Primitive, Peripheral - 14 Studies Found
Status | Study |
Completed |
Study Name: BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. Condition: Pancreatic Neuroendocrine Tumors (pNET) Date: 2012-07-06 Interventions: Drug: BEZ235 (Stage 1) The investigational study drug used in this trial was BEZ235, which was supplied |
Active, not recruiting |
Study Name: Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) Condition:
Date: 2012-02-27 Interventions: |
Completed |
Study Name: IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor Condition:
|
Completed |
Study Name: High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood Condition:
|
Completed |
Study Name: Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma Condition: Sarcoma Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer Condition:
Date: 1999-11-01 Interventions:
|
Terminated |
Study Name: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET Condition: Islet Cell Tumor Date: 2011-06-14 Interventions:
|
Terminated |
Study Name: Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors Condition: Pancreatic Neuroendocrine Tumors (pNET) Date: 2012-06-25 Interventions:
|
Recruiting |
Study Name: International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma Condition: Brain Tumors Date: 2014-02-07 Interventions:
|
Terminated |
Study Name: Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs Condition:
|